# N4 Pharma could attract a corporate partner far earlier than expected says SP Angel (Analyst Interview)

- Link: https://www.directorstalkinterviews.com/n4-pharma-could-attract-a-corporate-partner-far-earlier-than-expected-says-sp-angel-analyst-interview/412938793
- Published: 2020-11-19T07:47:32+00:00
- Author: Giles

**N4 Pharma plc** (LON:N4P) is the topic of conversation when SP Angel Analyst and
Head of Healthcare Vadim Alexandre joins DirectorsTalk. Vadim having just initiated
on the company explains what N4P does, the particular areas the business is involved
in, the current workstreams, how the covid pandemic has affected the company and
where Vadim sees value in the company.

N4 Pharma are a specialist pharmaceutical company developing a novel silica nanoparticle
delivery system for vaccines and therapeutics for licensing to pharmaceutical and
biotech partners. This nanoparticle has the potential to help commercialise cancer
immunotherapy drugs and improve the effectiveness of viral vaccines.

Share on: